India's Sun Pharma gets U.S. subpoena over generic drugs pricing

MUMBAI, May 28 (Reuters) - The U.S. Department of Justice

(DoJ) has subpoenaed India's largest drugmaker Sun

Pharmaceutical Industries Ltd seeking information about

the pricing and marketing of the...

Read more